Discontinuation report FLOMAX CR
| Report ID | 213714 |
| Drug Identification Number | 02270102 |
| Brand name | FLOMAX CR |
| Common or Proper name | FLOMAX CR |
| Company Name | BOEHRINGER INGELHEIM (CANADA) LTD LTEE |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | TAMSULOSIN HYDROCHLORIDE |
| Strength(s) | 0.4MG |
| Dosage form(s) | TABLET (EXTENDED-RELEASE) |
| Route of administration | ORAL ORAL |
| Packaging size | 3 X 10 |
| ATC code | G04CA |
| ATC description | DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2024-02-29 |
| Actual discontinuation date | 2024-02-16 |
| Remaining supply date | 2024-02-15 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | Final supply quantity received and available January 23, 2024 depleted. |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | Yes |
| Contact Address | 5180 SOUTH SERVICE ROAD BURLINGTON, ONTARIO CANADA L7L 5H4 |
| Company contact information | 1800 263 2425 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v13 | 2024-02-17 | English | Compare |
| v12 | 2024-02-16 | French | Compare |
| v11 | 2024-02-16 | French | Compare |
| v10 | 2024-02-16 | English | Compare |
| v9 | 2024-01-30 | English | Compare |
| v8 | 2024-01-26 | French | Compare |
| v7 | 2024-01-26 | English | Compare |
| v6 | 2024-01-26 | English | Compare |
| v5 | 2023-12-18 | French | Compare |
| v4 | 2023-12-18 | English | Compare |
| v3 | 2023-12-18 | English | Compare |
| v2 | 2023-12-18 | English | Compare |
| v1 | 2023-12-18 | English | Compare |
Showing 1 to 13 of 13